Article info
Commentary
Can we improve survival with less overall morbidity for patients with intermediate-risk cervical cancer without the use of external beam radiotherapy?
- Correspondence to Professor Cyrus Chargari, University Hospital Pitié Salpêtrière, Paris, Île-de-France, France; cyrus.chargari{at}aphp.fr
Citation
Can we improve survival with less overall morbidity for patients with intermediate-risk cervical cancer without the use of external beam radiotherapy?
Publication history
- Received January 16, 2023
- Accepted January 26, 2023
- First published February 7, 2023.
Article Versions
- You are currently viewing a Previous version of this article (7 February 2023).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.